Key result
Although DXA-derived visceral adipose tissue was strongly associated with MRI at baseline (r=0.90, P<0.001), it showed proportional bias and lacked validity for detecting longitudinal changes.
Why the study?
Accurate visceral adipose tissue quantification requires MRI, which incurs significant financial and time burdens, leading investigators to evaluate DXA-derived accuracy cross-sectionally and longitudinally.
Does DXA accurately measure visceral adipose tissue compared to MRI in children with normal weight and obesity?
Does DXA accurately measure visceral adipose tissue compared to MRI in children with normal weight and obesity?
Effect estimate: r = 0.90
p-value: p=<0.001
DXA lacks validity for detecting longitudinal changes in visceral adipose tissue among children with obesity compared to the MRI gold standard.
DXA-VAT overestimation may limit individual risk assessment in children; leaves open its surrogate role in pediatric obesity research.
Background . Increased visceral adipose tissue (VAT) is strongly associated with cardiometabolic risk factors. Accurate quantification of VAT is available through magnetic resonance imaging (MRI), which incurs a significant financial and time burden. We aimed to assess the accuracy of dual-energy X-ray absorptiometry- (DXA-) derived VAT (DXA-VAT) against a gold standard MRI protocol (MRI-VAT) in children with normal weight and obesity cross-sectionally, and over the course of a lifestyle intervention. Methodology . MRI-VAT and DXA-VAT were quantified in 61 children (30 normal weight and 31 with obesity) at baseline. Children with obesity entered a three-month exercise and/or nutrition intervention after which VAT was reassessed. MRI- and DXA-VAT cross-sectional area, volume, and mass were quantified, and associations were calculated at baseline ( n = 61) and pre-post intervention ( n = 28, 3 participants dropped out). Method agreement was assessed through Bland–Altman analysis, linear regression, and Passing–Bablok regression. Results . At baseline, all DXA- and MRI-VAT outcomes were strongly associated ( r = 0.90, P<0.001). However, there were no significant associations between absolute or relative change in DXA- and MRI-VAT outcomes ( r = 0.25–0.36, P>0.05). DXA significantly overestimated VAT CSA (cross-sectional area), volume, and mass when compared with MRI (P<0.001) at baseline. Significant proportional bias was observed for all DXA-VAT outcomes at baseline and for relative longitudinal changes in DXA-VAT. Conclusions . Although DXA-VAT outcomes were strongly associated with MRI-VAT outcomes at baseline, estimates were subject to proportional bias in children with obesity and normal weight. DXA lacks validity for detecting changes in VAT among children with obesity. This trial is registered with NCT01991106 .
No takes yet. Share an insight, caveat, or question.
Dias et al. (2019) studied Obesity (n=61). Dual-energy X-ray absorptiometry (DXA) vs. Magnetic resonance imaging (MRI) was evaluated on Association between DXA-VAT and MRI-VAT outcomes at baseline (r = 0.90, p=<0.001). Although DXA-derived visceral adipose tissue was strongly associated with MRI at baseline (r=0.90, P<0.001), it showed proportional bias and lacked validity for detecting longitudinal changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: